Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,293 publicly listed stocks with a combined market cap of $2.12 Trillion. Vertex Pharmaceuticals Inc leads the sector with a market cap of $130.90 Billion. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$2.12 Trillion
Companies Listed
1,293
Largest Company
Vertex Pharmaceuticals Inc
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX |
$130.90 Billion | $130.90 Billion | USA | $519.51 | +0.79% | -6.89% | 23.96 Million |
| 2 |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN |
$80.28 Billion | $80.28 Billion | USA | $793.74 | +1.57% | -5.90% | 14.31 Million |
| 3 |
CSL Ltd
AU:CSL |
$58.90 Billion | AU$83.24 Billion | Australia | AU$171.57 | +2.68% | -1.68% | 34.65 Million |
| 4 |
Moderna Inc
NASDAQ:MRNA |
$54.14 Billion | $54.14 Billion | USA | $146.69 | +1.89% | -1.46% | 699.69 Million |
| 5 |
Argen-X
BR:ARGX |
$47.46 Billion | €40.60 Billion | Belgium | €867.80 | +1.64% | -2.89% | 1.79 Million |
| 6 |
argenx NV ADR
NASDAQ:ARGX |
$45.97 Billion | $45.97 Billion | USA | $787.95 | -0.66% | -6.29% | 7.48 Million |
| 7 |
UCB S.A. UNSP.ADR 1/2
F:UNC0 |
$44.84 Billion | €38.35 Billion | Germany | €120.00 | -2.44% | -11.11% | 1.13K |
| 8 |
Samsung Biologics Co Ltd
KO:207940 |
$44.55 Billion | ₩65.73 Trillion | Korea | ₩1420000.00 | +0.35% | -1.87% | 1.09 Million |
| 9 |
Revolution Medicines Inc
NASDAQ:RVMD |
$43.96 Billion | $43.96 Billion | USA | $205.11 | +0.66% | -2.73% | 39.53 Million |
| 10 |
Argen-X
F:1AE |
$41.67 Billion | €35.64 Billion | Germany | €844.20 | -0.82% | -6.22% | 297.00 |
| 11 |
CSL LTD SPON.ADR 2
F:CSJA |
$40.06 Billion | €34.26 Billion | Germany | €18.20 | -3.19% | -9.90% | 420.00 |
| 12 |
UCB SA
BR:UCB |
$39.45 Billion | €33.74 Billion | Belgium | €210.50 | +2.38% | -0.05% | 4.94 Million |
| 13 |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY |
$33.15 Billion | $33.15 Billion | USA | $249.99 | +0.53% | -5.49% | 38.87 Million |
| 14 |
BeiGene, Ltd.
NASDAQ:ONC |
$32.38 Billion | $32.38 Billion | USA | $353.83 | +2.11% | -2.44% | 8.72 Million |
| 15 |
Celltrion Inc
KO:068270 |
$27.79 Billion | ₩41.00 Trillion | Korea | ₩178800.00 | +0.34% | -4.94% | 11.27 Million |
| 16 |
Insmed Inc
NASDAQ:INSM |
$26.72 Billion | $26.72 Billion | USA | $125.30 | -3.18% | -1.09% | 44.24 Million |
| 17 |
Royalty Pharma Plc
NASDAQ:RPRX |
$26.18 Billion | $26.18 Billion | USA | $59.05 | +0.75% | -7.56% | 70.13 Million |
| 18 |
BeiGene Ltd.
F:49B |
$25.73 Billion | €22.01 Billion | Germany | €17.34 | +0.00% | +0.00% | 0.00 |
| 19 |
Incyte Corporation
NASDAQ:INCY |
$24.43 Billion | $24.43 Billion | USA | $122.19 | +0.59% | -4.54% | 28.96 Million |
| 20 |
Roivant Sciences Ltd
NASDAQ:ROIV |
$20.44 Billion | $20.44 Billion | USA | $41.02 | +0.49% | +19.21% | 194.72 Million |
| 21 |
Genmab A/S
CO:GMAB |
$20.39 Billion | Dkr130.34 Billion | Denmark | Dkr2116.00 | +1.15% | -2.26% | 2.48 Million |
| 22 |
BioNTech SE
F:22UA |
$20.05 Billion | €17.15 Billion | Germany | €86.55 | +4.72% | -2.20% | 26.17K |
| 23 |
Innovent Biologics Inc
F:6IB |
$17.98 Billion | €15.38 Billion | Germany | €10.12 | -0.59% | -9.13% | 2.52K |
| 24 |
Genmab AS
NASDAQ:GMAB |
$16.23 Billion | $16.23 Billion | USA | $32.65 | +0.55% | -5.11% | 57.37 Million |
| 25 |
GENMAB AS SP.ADR/1/10DK 1
F:GE91 |
$15.06 Billion | €12.88 Billion | Germany | €23.80 | +3.48% | -2.46% | 68.00 |
| 26 |
WUXI BIOLOGICS UNSP.ADR/2
F:1FW1 |
$14.75 Billion | €12.62 Billion | Germany | €7.20 | -2.04% | -9.43% | 42.00K |
| 27 |
Ascendis Pharma AS
NASDAQ:ASND |
$14.74 Billion | $14.74 Billion | USA | $264.92 | +0.53% | -2.29% | 12.50 Million |
| 28 |
WUXI BIOLOGICS-00000083
F:1FW2 |
$14.60 Billion | €12.49 Billion | Germany | €5.34 | +5.12% | -3.44% | 12.21K |
| 29 |
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ |
$14.17 Billion | $14.17 Billion | USA | $245.87 | +0.03% | -0.68% | 22.29 Million |
| 30 |
Summit Therapeutics PLC
NASDAQ:SMMT |
$13.99 Billion | $13.99 Billion | USA | $18.42 | +4.96% | +7.53% | 152.01 Million |
| 31 |
BridgeBio Pharma Inc
NASDAQ:BBIO |
$13.87 Billion | $13.87 Billion | USA | $72.38 | -0.08% | -4.02% | 47.85 Million |
| 32 |
Ascendis Pharma AS
F:A71 |
$12.65 Billion | €10.82 Billion | Germany | €206.00 | +0.98% | +4.04% | 166.00 |
| 33 |
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
$12.51 Billion | $12.51 Billion | USA | $66.41 | +1.11% | -0.03% | 45.60 Million |
| 34 |
ALTEOGEN Inc
KQ:196170 |
$12.26 Billion | ₩18.09 Trillion | Korea | ₩260000.00 | -2.99% | -9.88% | 15.15 Million |
| 35 |
Exelixis Inc
NASDAQ:EXEL |
$12.17 Billion | $12.17 Billion | USA | $56.21 | +0.16% | -4.94% | 49.53 Million |
| 36 |
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL |
$11.90 Billion | $11.90 Billion | USA | $518.74 | -1.97% | +0.03% | 8.60 Million |
| 37 |
Jazz Pharmaceuticals plc
F:J7Z |
$11.86 Billion | €10.14 Billion | Germany | €212.80 | +0.61% | +0.42% | 58.00 |
| 38 |
Bio-Techne Corp
NASDAQ:TECH |
$11.33 Billion | $11.33 Billion | USA | $72.27 | +0.21% | -0.25% | 56.62 Million |
| 39 |
Axsome Therapeutics Inc
NASDAQ:AXSM |
$11.30 Billion | $11.30 Billion | USA | $216.58 | -1.89% | +3.95% | 14.30 Million |
| 40 |
Avidity Biosciences, Inc
NASDAQ:RNAM |
$11.02 Billion | $11.02 Billion | USA | $71.34 | +0.00% | +0.00% | 0.00 |
| 41 |
Xizang Haisco Pharmaceutical Group Co Ltd
SHE:002653 |
$10.68 Billion | CN¥73.02 Billion | China | CN¥64.00 | +2.25% | -7.50% | 138.20 Million |
| 42 |
AKESO INC. O.N.
F:4RY |
$10.42 Billion | €8.91 Billion | Germany | €10.48 | +5.83% | -4.82% | 3.55K |
| 43 |
Cytokinetics Inc
NASDAQ:CYTK |
$10.07 Billion | $10.07 Billion | USA | $72.45 | -1.79% | -2.03% | 40.90 Million |
| 44 |
Abivax SA American Depositary Shares
NASDAQ:ABVX |
$9.91 Billion | $9.91 Billion | USA | $113.58 | -4.27% | -0.40% | 21.65 Million |
| 45 |
Krystal Biotech Inc
NASDAQ:KRYS |
$9.72 Billion | $9.72 Billion | USA | $340.03 | -2.01% | -8.46% | 5.19 Million |
| 46 |
Kymera Therapeutics Inc
NASDAQ:KYMR |
$9.43 Billion | $9.43 Billion | USA | $114.63 | -0.29% | -2.26% | 16.88 Million |
| 47 |
Pharmaron Beijing Co Ltd
SHE:300759 |
$9.22 Billion | CN¥62.98 Billion | China | CN¥42.65 | +5.88% | +3.54% | 1.48 Billion |
| 48 |
Praxis Precision Medicines Inc
NASDAQ:PRAX |
$9.22 Billion | $9.22 Billion | USA | $330.55 | -1.20% | -6.93% | 7.71 Million |
| 49 |
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR |
$9.19 Billion | $9.19 Billion | USA | $80.67 | -2.63% | -6.73% | 29.70 Million |
| 50 |
Nuvalent Inc
NASDAQ:NUVL |
$9.12 Billion | $9.12 Billion | USA | $123.96 | +0.00% | +0.13% | 54.40 Million |
| 51 |
Verona Pharma plc
F:I9SA |
$9.07 Billion | €7.76 Billion | Germany | €90.20 | +0.67% | +0.22% | 341.00 |
| 52 |
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX |
$9.01 Billion | $9.01 Billion | USA | $84.95 | +0.00% | +0.20% | 55.12 Million |
| 53 |
Vaxcyte Inc
NASDAQ:PCVX |
$8.86 Billion | $8.86 Billion | USA | $59.54 | +0.12% | -2.66% | 24.30 Million |
| 54 |
Abivax SA
PA:ABVX |
$8.82 Billion | €7.55 Billion | France | €99.65 | -1.63% | +2.10% | 3.39 Million |
| 55 |
Halozyme Therapeutics Inc
NASDAQ:HALO |
$8.70 Billion | $8.70 Billion | USA | $107.94 | +0.69% | -2.55% | 40.79 Million |
| 56 |
Asymchem Laboratories Tian Jin Co Ltd
SHE:002821 |
$8.65 Billion | CN¥59.13 Billion | China | CN¥177.60 | +8.21% | +8.94% | 285.09 Million |
| 57 |
Ionis Pharmaceuticals Inc
NASDAQ:IONS |
$8.55 Billion | $8.55 Billion | USA | $51.44 | -5.11% | -11.51% | 62.44 Million |
| 58 |
Tubize-Fin
BR:TUB |
$8.48 Billion | €7.26 Billion | Belgium | €178.60 | +1.71% | -0.06% | 400.11K |
| 59 |
Blueprint Medicines Corp
NASDAQ:BPMC |
$8.36 Billion | $8.36 Billion | USA | $129.46 | +0.00% | +0.00% | 2.98 Million |
| 60 |
Apogee Therapeutics, Inc. Common Stock
NASDAQ:APGE |
$8.33 Billion | $8.33 Billion | USA | $135.07 | -0.01% | +0.16% | 34.02 Million |
| 61 |
TG Therapeutics Inc
NASDAQ:TGTX |
$8.27 Billion | $8.27 Billion | USA | $54.00 | +0.20% | -4.78% | 42.91 Million |
| 62 |
Twist Bioscience Corp
NASDAQ:TWST |
$8.26 Billion | $8.26 Billion | USA | $134.75 | +5.92% | +4.69% | 37.18 Million |
| 63 |
Spyre Therapeutics Inc.
NASDAQ:SYRE |
$8.01 Billion | $8.01 Billion | USA | $90.80 | +0.22% | +4.07% | 25.93 Million |
| 64 |
Immunovant Inc
NASDAQ:IMVT |
$7.78 Billion | $7.78 Billion | USA | $37.66 | +0.80% | -3.73% | 28.26 Million |
| 65 |
Verona Pharma PLC ADR
NASDAQ:VRNA |
$7.31 Billion | $7.31 Billion | USA | $86.00 | +0.00% | -2.27% | 31.77 Million |
| 66 |
Cidara Therapeutics Inc
NASDAQ:CDTX |
$6.96 Billion | $6.96 Billion | USA | $221.38 | +0.03% | +0.26% | 24.25 Million |
| 67 |
Merus BV
NASDAQ:MRUS |
$6.83 Billion | $6.83 Billion | USA | $90.00 | -7.14% | -7.02% | 27.33 Million |
| 68 |
Caris Life Sciences, Inc. Common Stock
NASDAQ:CAI |
$6.79 Billion | $6.79 Billion | USA | $26.05 | +7.03% | +2.88% | 115.53 Million |
| 69 |
Arcellx Inc
NASDAQ:ACLX |
$6.73 Billion | $6.73 Billion | USA | $115.07 | +0.00% | +0.06% | 44.08 Million |
| 70 |
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578 |
$6.66 Billion | CN¥45.51 Billion | China | CN¥101.14 | +1.66% | -8.51% | 151.95 Million |
| 71 |
Belite Bio Inc ADR
NASDAQ:BLTE |
$6.17 Billion | $6.17 Billion | USA | $164.45 | -1.77% | -2.55% | 3.65 Million |
| 72 |
ALK-Abelló A/S
CO:ALK-B |
$6.15 Billion | Dkr39.29 Billion | Denmark | Dkr195.20 | -0.36% | -6.51% | 6.04 Million |
| 73 |
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA |
$6.10 Billion | $6.10 Billion | USA | $39.43 | -0.10% | -0.45% | 113.44 Million |
| 74 |
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND |
$6.09 Billion | $6.09 Billion | USA | $280.65 | -1.34% | -2.19% | 4.66 Million |
| 75 |
Oruka Therapeutics, Inc.
NASDAQ:ORKA |
$6.06 Billion | $6.06 Billion | USA | $95.93 | +3.84% | +5.43% | 18.63 Million |
| 76 |
Dianthus Therapeutics Inc.
NASDAQ:DNTH |
$5.99 Billion | $5.99 Billion | USA | $107.69 | +1.40% | -0.15% | 14.48 Million |
| 77 |
Immunitybio Inc
NASDAQ:IBRX |
$5.96 Billion | $5.96 Billion | USA | $8.37 | +5.82% | +2.20% | 185.96 Million |
| 78 |
Mirum Pharmaceuticals Inc
NASDAQ:MIRM |
$5.90 Billion | $5.90 Billion | USA | $96.75 | -1.50% | -3.86% | 11.96 Million |
| 79 |
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM |
$5.84 Billion | $5.84 Billion | USA | $102.44 | -2.17% | -2.34% | 11.78 Million |
| 80 |
CG Oncology, Inc. Common stock
NASDAQ:CGON |
$5.79 Billion | $5.79 Billion | USA | $73.79 | +1.99% | -0.73% | 16.25 Million |
| 81 |
Erasca Inc
NASDAQ:ERAS |
$5.65 Billion | $5.65 Billion | USA | $16.16 | +1.76% | -0.62% | 88.36 Million |
| 82 |
Corcept Therapeutics Incorporated
NASDAQ:CORT |
$5.61 Billion | $5.61 Billion | USA | $111.80 | -0.88% | -0.89% | 19.44 Million |
| 83 |
PTC Therapeutics Inc
NASDAQ:PTCT |
$5.51 Billion | $5.51 Billion | USA | $66.48 | +0.64% | -6.89% | 19.82 Million |
| 84 |
Cogent Biosciences Inc
NASDAQ:COGT |
$5.42 Billion | $5.42 Billion | USA | $33.41 | +0.00% | -4.41% | 39.68 Million |
| 85 |
Bachem Holding AG
SW:BANB |
$5.42 Billion | CHF4.29 Billion | Switzerland | CHF76.50 | -0.58% | -0.78% | 2.28 Million |
| 86 |
Definium Therapeutics, Inc.
NASDAQ:DFTX |
$5.34 Billion | $5.34 Billion | USA | $40.25 | +3.50% | +5.92% | 53.75 Million |
| 87 |
Crispr Therapeutics AG
NASDAQ:CRSP |
$5.11 Billion | $5.11 Billion | USA | $52.96 | +2.40% | -6.25% | 33.15 Million |
| 88 |
Protagonist Therapeutics Inc
NASDAQ:PTGX |
$5.09 Billion | $5.09 Billion | USA | $147.78 | -0.27% | -0.69% | 11.68 Million |
| 89 |
3SBio Inc
F:83B |
$5.07 Billion | €4.34 Billion | Germany | €1.74 | +5.51% | +0.66% | 250.00 |
| 90 |
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SHG:603392 |
$4.84 Billion | CN¥33.08 Billion | China | CN¥26.16 | -0.46% | -5.46% | 207.48 Million |
| 91 |
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
$4.78 Billion | CN¥32.63 Billion | China | CN¥4.95 | +1.23% | +0.61% | 1.07 Billion |
| 92 |
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD |
$4.74 Billion | $4.74 Billion | USA | $27.52 | -1.11% | -1.22% | 33.22 Million |
| 93 |
Scholar Rock Holding Corp
NASDAQ:SRRK |
$4.69 Billion | $4.69 Billion | USA | $51.85 | -6.42% | -7.31% | 28.85 Million |
| 94 |
Amicus Therapeutics Inc
NASDAQ:FOLD |
$4.55 Billion | $4.55 Billion | USA | $14.49 | +0.00% | +0.21% | 59.70 Million |
| 95 |
Akero Therapeutics Inc
NASDAQ:AKRO |
$4.50 Billion | $4.50 Billion | USA | $54.65 | +0.00% | +0.39% | 64.49 Million |
| 96 |
Parabilis Medicines, Inc. Common Stock
NASDAQ:PBLS |
$4.41 Billion | $4.41 Billion | USA | $36.16 | -1.95% | -11.26% | 9.68 Million |
| 97 |
Chongqing Zhifei Bio Products
SHE:300122 |
$4.38 Billion | CN¥29.95 Billion | China | CN¥12.51 | -0.79% | -5.58% | 1.14 Billion |
| 98 |
Suzhou Zelgen Biopharmaceuticals Co Ltd
SHG:688266 |
$4.29 Billion | CN¥29.35 Billion | China | CN¥110.88 | +3.95% | -6.03% | 126.82 Million |
| 99 |
Sk Biopharmaceuticals Co Ltd
KO:326030 |
$4.20 Billion | ₩6.19 Trillion | Korea | ₩79100.00 | -0.38% | -8.66% | 3.59 Million |
| 100 |
Tango Therapeutics Inc
NASDAQ:TNGX |
$4.14 Billion | $4.14 Billion | USA | $24.54 | +3.20% | +7.82% | 53.61 Million |
| 101 |
Metsera, Inc. Common Stock
NASDAQ:MTSR |
$4.12 Billion | $4.12 Billion | USA | $70.50 | +0.00% | -13.55% | 97.45 Million |
| 102 |
Enliven Therapeutics Inc.
NASDAQ:ELVN |
$3.99 Billion | $3.99 Billion | USA | $54.43 | +0.20% | -8.75% | 20.85 Million |
| 103 |
Travere Therapeutics Inc
NASDAQ:TVTX |
$3.96 Billion | $3.96 Billion | USA | $65.79 | -0.57% | -1.13% | 28.99 Million |
| 104 |
Veradermics, Incorporated
NYSE:MANE |
$3.94 Billion | $3.94 Billion | USA | $101.70 | +2.76% | +4.04% | 14.02 Million |
| 105 |
Celcuity LLC
NASDAQ:CELC |
$3.87 Billion | $3.87 Billion | USA | $83.53 | +0.10% | -13.38% | 19.87 Million |
| 106 |
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX |
$3.85 Billion | $3.85 Billion | USA | $31.49 | +0.00% | +0.06% | 53.87 Million |
| 107 |
Camurus AB
ST:CAMX |
$3.81 Billion | Skr35.43 Billion | Sweden | Skr594.00 | +1.71% | +1.19% | 1.40 Million |
| 108 |
Ideaya Biosciences Inc
NASDAQ:IDYA |
$3.67 Billion | $3.67 Billion | USA | $38.03 | +1.17% | -4.85% | 16.13 Million |
| 109 |
Edgewise Therapeutics Inc
NASDAQ:EWTX |
$3.66 Billion | $3.66 Billion | USA | $44.62 | +0.50% | +6.36% | 24.39 Million |
| 110 |
Shanghai Junshi Biosciences Co Ltd
SHG:688180 |
$3.64 Billion | CN¥24.88 Billion | China | CN¥32.50 | +4.37% | -2.96% | 440.88 Million |
| 111 |
Legend Biotech Corp
NASDAQ:LEGN |
$3.60 Billion | $3.60 Billion | USA | $18.53 | -0.59% | -14.80% | 49.37 Million |
| 112 |
Beijing Tiantan Biological Products Corp Ltd
SHG:600161 |
$3.56 Billion | CN¥24.36 Billion | China | CN¥12.32 | +1.90% | +0.33% | 321.38 Million |
| 113 |
SpringWorks Therapeutics Inc
NASDAQ:SWTX |
$3.54 Billion | $3.54 Billion | USA | $46.99 | +0.00% | +0.00% | 5.01 Million |
| 114 |
Tarsus Pharmaceuticals Inc
NASDAQ:TARS |
$3.51 Billion | $3.51 Billion | USA | $79.95 | +0.81% | -3.91% | 18.13 Million |
| 115 |
Hualan Biological EngineeringInc
SHE:002007 |
$3.50 Billion | CN¥23.88 Billion | China | CN¥13.07 | +2.11% | +0.23% | 324.69 Million |
| 116 |
Denali Therapeutics Inc
NASDAQ:DNLI |
$3.39 Billion | $3.39 Billion | USA | $21.22 | +0.62% | -6.93% | 27.94 Million |
| 117 |
Genscript Biotech Corporation
F:G51 |
$3.36 Billion | €2.88 Billion | Germany | €3.70 | +5.71% | +6.32% | 444.00 |
| 118 |
Viking Therapeutics Inc
NASDAQ:VKTX |
$3.35 Billion | $3.35 Billion | USA | $31.53 | -1.41% | -7.21% | 41.71 Million |
| 119 |
TELIX Pharmaceuticals Ltd
AU:TLX |
$3.27 Billion | AU$4.62 Billion | Australia | AU$16.34 | +4.28% | -0.79% | 44.31 Million |
| 120 |
Xenon Pharmaceuticals Inc
NASDAQ:XENE |
$3.24 Billion | $3.24 Billion | USA | $58.19 | -0.78% | -3.66% | 15.35 Million |
| 121 |
ABCELLERA BIOLOGICS
F:8QQ |
$3.15 Billion | €2.69 Billion | Germany | €9.30 | +3.33% | -5.78% | 24.46K |
| 122 |
Zealand Pharma A/S
CO:ZEAL |
$3.07 Billion | Dkr19.63 Billion | Denmark | Dkr278.70 | +0.18% | -8.74% | 9.99 Million |
| 123 |
Xiamen Amoytop Biotech Co Ltd
SHG:688278 |
$3.06 Billion | CN¥20.94 Billion | China | CN¥51.30 | -1.44% | -9.94% | 109.93 Million |
| 124 |
Dyne Therapeutics Inc
NASDAQ:DYN |
$3.06 Billion | $3.06 Billion | USA | $18.52 | +1.70% | -25.77% | 64.26 Million |
| 125 |
Celldex Therapeutics Inc
NASDAQ:CLDX |
$3.06 Billion | $3.06 Billion | USA | $39.18 | +6.18% | -0.48% | 17.90 Million |
| 126 |
Arcutis Biotherapeutics Inc
NASDAQ:ARQT |
$3.05 Billion | $3.05 Billion | USA | $24.27 | +1.61% | +2.58% | 42.02 Million |
| 127 |
Hebei Changshan Biochem Pharma
SHE:300255 |
$3.04 Billion | CN¥20.78 Billion | China | CN¥22.61 | +0.49% | -2.50% | 670.08 Million |
| 128 |
Arcus Biosciences Inc
NYSE:RCUS |
$3.03 Billion | $3.03 Billion | USA | $24.07 | -2.11% | -20.11% | 31.76 Million |
| 129 |
Abcellera Biologics Inc
NASDAQ:ABCL |
$2.99 Billion | $2.99 Billion | USA | $11.17 | +2.57% | -3.46% | 169.33 Million |
| 130 |
Relay Therapeutics Inc
NASDAQ:RLAY |
$2.95 Billion | $2.95 Billion | USA | $19.06 | +1.01% | +0.26% | 63.83 Million |
| 131 |
BB Biotech AG
SW:BION |
$2.93 Billion | CHF2.32 Billion | Switzerland | CHF52.40 | -0.19% | -4.90% | 1.84 Million |
| 132 |
Immunome Inc
NASDAQ:IMNM |
$2.79 Billion | $2.79 Billion | USA | $24.55 | -0.49% | -9.61% | 24.43 Million |
| 133 |
Soleno Therapeutics Inc
NASDAQ:SLNO |
$2.76 Billion | $2.76 Billion | USA | $53.01 | +0.00% | +0.11% | 48.81 Million |
| 134 |
Zai Lab Ltd
NASDAQ:ZLAB |
$2.76 Billion | $2.76 Billion | USA | $24.58 | +1.82% | -8.96% | 28.55 Million |
| 135 |
Structure Therapeutics Inc. American Depositary Shares
NASDAQ:GPCR |
$2.74 Billion | $2.74 Billion | USA | $38.44 | -0.57% | -18.80% | 20.33 Million |
| 136 |
HLB Co. Ltd
KQ:028300 |
$2.73 Billion | ₩4.03 Trillion | Korea | ₩30350.00 | -3.50% | -10.07% | 29.96 Million |
| 137 |
ATAI Life Sciences BV
NASDAQ:ATAI |
$2.69 Billion | $2.69 Billion | USA | $7.35 | +0.00% | +0.00% | 286.56 Million |
| 138 |
Pharvaris BV
NASDAQ:PHVS |
$2.65 Billion | $2.65 Billion | USA | $38.86 | +2.21% | +8.97% | 23.59 Million |
| 139 |
Disc Medicine Inc.
NASDAQ:IRON |
$2.65 Billion | $2.65 Billion | USA | $68.92 | -1.63% | -13.17% | 10.77 Million |
| 140 |
BioArctic AB (publ)
ST:BIOA-B |
$2.60 Billion | Skr24.19 Billion | Sweden | Skr325.40 | +1.81% | -2.57% | 4.38 Million |
| 141 |
KEYMED BIOSCIENCES -0001
F:64Z |
$2.59 Billion | €2.22 Billion | Germany | €8.10 | +2.53% | -5.81% | 0.00 |
| 142 |
NewAmsterdam Pharma Company N.V. Ordinary Shares
NASDAQ:NAMS |
$2.54 Billion | $2.54 Billion | USA | $22.36 | -1.93% | -13.50% | 31.78 Million |
| 143 |
Beam Therapeutics Inc
NASDAQ:BEAM |
$2.49 Billion | $2.49 Billion | USA | $24.12 | +0.54% | -18.13% | 43.61 Million |
| 144 |
ABL Bio Inc
KQ:298380 |
$2.46 Billion | ₩3.63 Trillion | Korea | ₩64900.00 | -1.82% | -9.10% | 5.97 Million |
| 145 |
Precigen Inc
NASDAQ:PGEN |
$2.43 Billion | $2.43 Billion | USA | $6.85 | +0.00% | -4.06% | 105.02 Million |
| 146 |
Bavarian Nordic
CO:BAVA |
$2.43 Billion | Dkr15.56 Billion | Denmark | Dkr203.00 | -0.39% | -5.84% | 5.69 Million |
| 147 |
Braveheart Bio, Inc. Common Stock
NASDAQ:BRVE |
$2.43 Billion | $2.43 Billion | USA | $27.02 | +1.43% | +2.85% | 8.22 Million |
| 148 |
Pharma Reaserch Prod Co Ltd
KQ:214450 |
$2.43 Billion | ₩3.59 Trillion | Korea | ₩345500.00 | +1.02% | -10.61% | 3.35 Million |
| 149 |
Adaptive Biotechnologies Corp
NASDAQ:ADPT |
$2.43 Billion | $2.43 Billion | USA | $24.78 | +2.40% | +0.85% | 41.60 Million |
| 150 |
Harmony Biosciences Holdings
NASDAQ:HRMY |
$2.42 Billion | $2.42 Billion | USA | $41.54 | +0.05% | -0.76% | 17.77 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries